Ontario Pharmacy Legislation, Regulations, and Practice Standards

Comprehensive vocabulary flashcards covering the Pharmacy Act, Regulated Health Professions Act (RHPA), Ontario Drug Benefit Act (ODBA), Drug Interchangeability and Dispensing Fee Act (DIDFA), Transparent Drug Systems for Patients Act (TDSPA), and the Drug and Pharmacies Regulation Act (DPRA).

Scope of Practice (Pharmacy Act)

The custody, compounding, dispensing, and prescribing of drugs; the provision of health care aids and devices; the provision of related information and education; and the promotion of health, prevention, and treatment of disease through monitoring and medication therapy management.

Controlled Acts

A list of $14$ specific health care procedures or activities defined under the Regulated Health Professions Act (RHPA) that pose a potential risk of harm to the public if performed by an unqualified individual.

Vaccine Administration by Injection (Pharmacy Act)

An authorized act allowing Part A pharmacists and pharmacy interns to administer influenza vaccines to individuals $2\,\text{years of age or older}$, while registered pharmacy technicians may administer influenza ($2+\text{ years}$), RSV ($5+\text{ years}$), and COVID-19 ($6+\text{ months}$) vaccines under specified regulatory conditions.

Schedule 4 (Pharmacy Act)

The specific list of drug categories and substances that Part A pharmacists or pharmacy interns are authorized to prescribe for the treatment of $19$ designated minor ailments.

Part B Pharmacist

A registration category for non-practicing pharmacists who are prohibited from providing patient care, dispensing, compounding, supervising a pharmacy, managing a dispensary, or mentoring students, and must identify as non-practicing in clinical settings.

Independent Technical Check

The authorized scope permitting a Registered Pharmacy Technician (RPHT) to independently verify the technical accuracy of a prescription, while the pharmacist retains exclusive responsibility for the therapeutic assessment.

Emergency Assignment (EA) Certificate of Registration

A time-limited certificate issued by OCP during an emergency declared by the College or Ontario government to ensure public access to pharmacy services, which expires $60\,\text{days}$ after issuance unless revoked or extended.

Restricted Titles (Pharmacy Act, Section 10(1))

Legally protected professional designations that only registered OCP members may use: 'apothecary', 'druggist', 'pharmacist', 'pharmacy technician', and 'pharmaceutical chemist' (including their variations, abbreviations, or equivalents).

Health Professions Regulatory Advisory Council (HPRAC)

An independent, arms-length statutory body appointed by the Lieutenant Governor in Council that advises the Minister of Health and Long-Term Care on regulating or deregulating health professions and amending health legislation.

Health Professions Procedural Code (Schedule 2, RHPA)

A uniform legislative code embedded in every health profession act that mandates College operations, including complaints, discipline, quality assurance, registration, and seven required statutory committees.

Accreditation Committee

A statutory committee under the Pharmacy Act that governs pharmacy operations in Ontario, evaluates new applications and annual renewals of certificates of accreditation, and addresses operational deficiencies identified during inspections.

Trillium Drug Program (TDP)

An Ontario Drug Benefit plan designed for Ontario residents with a valid OHIP card who have high prescription drug costs relative to their household income and lack comprehensive private insurance coverage.

Comparative Drug Index (CDI)

Part III-A of the ODB Formulary that identifies eligible drug benefits by pharmacologic therapeutic classification and lists designations of interchangeable generic products along with their drug benefit prices.

ODB Deductible (Seniors)

An annual deductible of $\$100$ (resetting every August 1st) paid by single seniors earning more than $\$25{,}000$ or senior couples earning more than $\$41{,}500$, after which a co-pay of $\$6.11$ per prescription applies.

Medically Necessary 'No Substitution' (ODB)

A policy where ODB covers the brand-name cost only if the patient has experienced documented adverse reactions to at least two interchangeable generics, the prescriber completes a Health Canada Vigilance ADR form, and 'NO SUB' is handwritten on the prescription.

Exceptional Access Program (EAP)

A mechanism for ODB recipients to obtain reimbursement for unlisted drug products required for clinical situations causing severe disability, requiring an Individual Clinical Review submitted by a physician to the Committee to Evaluate Drugs.

Limited Use (LU) Product

A drug product restricted to specific clinical criteria and reimbursed by ODB only when the prescriber provides an approved $3\text{-digit}$ Reason for Use (RFU) code valid for an authorized time period.

ODB Trial Program

A policy mandating that new prescriptions for ODB recipients be dispensed initially as a $30\text{-day}$ supply unless overridden due to prior use within $12\,\text{months}$, non-splittable dosage forms, or patient inability to return.

ODB Vacation Supply

An early refill policy permitting ODB recipients travelling outside Ontario for $100\text{ to }200\,\text{days}$ to receive a second supply of up to $100\,\text{days}$ upon submitting written verification, which must be retained on file for $24\,\text{months}$.

Chronic Medication Dispensing Fee Cap

An ODB policy limiting reimbursement to a maximum of $5$ dispensing fees per patient per drug per year across $15$ designated chronic medication categories (with exemptions for Ontario Works and LTC residents).

MedsCheck Program

A government-funded medication therapy management service launched on April 1, 2007, where pharmacists conduct comprehensive annual reviews ($\$60$), diabetes reviews ($\$75$), home consultations ($\$150$), or quarterly LTC consultations.

Pharmaceutical Opinion

A remunerated clinical service ($\$15$ per intervention) where a pharmacist identifies a drug therapy problem, documents the issue, and contacts the prescriber to recommend modifying, confirming, or withholding therapy.

Interchangeable Drug (DIDFA)

A drug product containing the identical active ingredients in the same strength and dosage form that has demonstrated equivalent therapeutic action in the body and is designated as interchangeable in the provincial formulary.

Off-Formulary Interchangeability (OFI)

A DIDFA provision enacted in 2007 listed in Part III-B of the Formulary that designates generic interchangeability for medications not funded by ODB, enabling cost savings for private payers and cash-paying patients.

Usual and Customary Professional Fee Notice

A mandatory, clear sign displayed adjacent to the dispensary area that shows the dispensing fee filed with the OCP Registrar and outlines the professional dispensing services included.

Transparent Drug Systems for Patients Act (TDSPA)

Ontario legislation (Bill 102) that establishes anti-rebate provisions under ODBA and DIDFA, strictly prohibiting drug manufacturers from offering or paying commercial rebates to pharmacies for dispensing generic products.

Drug (DPRA Definition)

Any substance or preparation listed in NAPRA Schedules I, II, or III, published in named reference texts, or specified in regulations, used to diagnose, treat, mitigate, prevent disease, or modify bodily functions (excluding food, drink, cosmetics, and unscheduled products).

DPRA Respiratory Warning Label

A mandatory warning displayed on systemic or internal bronchodilators/adrenergics stating: 'WARNING: Do not exceed the dose prescribed by your physician. If difficulty in breathing persists, contact your physician immediately.'

Child Resistant Packaging (DPRA)

A certified safety container meeting Canadian Standards Association requirements that must be used for dispensing all prescriptions unless specifically directed otherwise by the prescriber or patient, or if deemed unsuitable by the pharmacist.

Prescription Transfer (DPRA)

The formal transfer of remaining authorized prescription refills directly between licensed pharmacies (within Canada only), after which the originating pharmacy marks the original record as transferred and cancels all remaining fills.

Remote Dispensing Location (RDL)

A retail dispensary site or Automated Pharmacy System (APS) operating at a physical location distinct from an accredited base pharmacy under the active, real-time supervision of a physically present pharmacist at the host site.

Pharmacist Authority to Refill Prescriptions (DPRA)

A regulatory power permitting community pharmacists to authorize a refill for chronic non-controlled medications for the lesser of the previous quantity or a $3\text{-month}$ supply when the prescriber cannot be reached, notifying the physician within $7\,\text{days}$.

Patient Record Retention Period (DPRA)

The mandatory duration for maintaining complete pharmacy patient profiles: at least $10\,\text{years}$ from the date of the last recorded professional service, or $10\,\text{years}$ from the date the patient turns $18\,\text{years of age}$.

Certificate of Accreditation

The operational license issued by OCP that permits a specific premise to operate as a pharmacy, which must be renewed annually by May 10th and requires pre-opening inspection.

OCP Routine Inspection Process

A cyclical practice assessment conducted every $3\,\text{years}$; satisfactory outcomes require no further action, while deficiencies require an action plan with a deadline, and extreme deficiencies trigger an action plan plus scheduled re-inspection (with persistent deficiencies referred to the Accreditation Committee).

Dispensary Physical Standards (DPRA)

Regulatory facility requirements prescribing a minimum total pharmacy area of $18.6\,\text{m}^2$ ($200\,\text{sq ft}$), a prescription compounding area of at least $9.3\,\text{m}^2$ ($100\,\text{sq ft}$) with $12\,\text{sq ft}$ of clear counter space, and dedicated drug refrigeration maintained at $2\text{ to }8\,^\circ\text{C}$.

Lock and Leave Enclosure

A physical security design allowing the retail portion of an establishment to stay open when a pharmacist is not on duty, requiring a physical barrier of at least $2.44\,\text{m}$ ($8\,\text{ft}$) in height, no more than $15\,\text{cm}$ from the floor, with all scheduled drugs kept at least $1\,\text{m}$ away.

Point of Care Symbol

A symbol indicating quality of care that may be used only by an accredited pharmacy and must be posted by at least one public entrance to the pharmacy.

Pharmacy Notice of Closure

The regulatory requirement to notify the OCP Registrar within $7\,\text{days}$ of closing, remove all external pharmacy signage, inform patients, and submit a completed closing package within $30\,\text{days}$ detailing the disposition of files and drugs.

Piggybacking Prohibition

The dispensing standard that forbids adding newly authorized refills onto the unfulfilled repeats of an earlier prescription; remaining repeats from the preceding authorization must be cancelled.

Scope of Practice (Pharmacy Act)

The statutory scope defined under Section 21(1) of the Pharmacy Act, which includes the custody, compounding, dispensing, and prescribing of drugs (as specified in regulations); the provision of healthcare aids and devices; the provision of information and education related to these; and the promotion of health, prevention, and treatment of disease, disorders, and dysfunctions through monitoring and management of medication therapy.

Authorized Acts (Pharmacy Act)

Specific clinical procedures granted to registered pharmacy professionals under Section 4 of the Pharmacy Act, including dispensing, selling, or compounding drugs; supervising where drugs are kept; administering specified substances by injection or inhalation for patient education or immunization; prescribing specified drugs for minor ailments; adapting or renewing prescriptions; and piercing the dermis with a lancet-type device to obtain blood.

Minor Ailments Prescribing

An authorized act permitting a Part A pharmacist or pharmacy intern with the required clinical judgment and skills to assess and prescribe designated Schedule 4 drugs for $19$ minor ailments, including examples such as varenicline (Champix) or bupropion (Zyban) for smoking cessation, bilastine (Blexten) for allergies, pantoprazole for GERD, and nitrofurantoin for uncomplicated urinary tract infections.

Prescription Adaptation and Renewal

The authority of a Part A pharmacist or pharmacy intern under the Pharmacy Act to alter the dose, dosage form, regimen, or route of administration of an existing prescription, or renew a prescription for continuity of care; this authority expressly excludes controlled substances under the CDSA, monitored drugs under the NSAA, and therapeutic substitution.

Part A Pharmacist

A class of registration on the Ontario College of Pharmacists register designating a pharmacist who is actively entitled to provide direct patient care, dispense, sell, compound, supervise a pharmacy, manage staff, and act as a designated manager.

Part B Pharmacist

A register class for non-practicing pharmacists who are prohibited from providing patient care, dispensing, compounding, selling drugs, supervising a pharmacy or designated staff, or serving as a designated manager, and who must identify themselves as non-practicing when in a patient care setting.

Registered Pharmacy Technician (RPHT)

A regulated member of the Ontario College of Pharmacists who ensures technical accuracy and independently checks the technical component of prescriptions under the direct supervision of a pharmacist in an accredited pharmacy; cannot supervise a pharmacy, delegate controlled acts, or provide education requiring clinical analysis or assessment.

Pharmacy Intern

A registrant holding a temporary certificate of registration while completing requirements to become a pharmacist; authorized to practice pharmacy only under the direct supervision of a licensed pharmacist, cannot supervise a pharmacy, and cannot delegate controlled acts (though controlled acts may be delegated to them).

Emergency Assignment (EA) Certificate of Registration

A temporary certificate issued by the College during declared emergency situations when increased availability of full-scope pharmacy professionals is needed; initially valid for $60\,\text{days}$, renewable or revocable by the Registrar, and expires $60\,\text{days}$ after emergency conditions cease.

Restricted Titles (Pharmacy Act, Section 10(1))

The protected professional designations reserved exclusively for registered members of the Ontario College of Pharmacists, specifically: 'apothecary', 'druggist', 'pharmacist', 'pharmacy technician', and 'pharmaceutical chemist', including any abbreviations or variations in any language.

Council of the Ontario College of Pharmacists

The governing board and policy-making body of the College, structured with $9\text{--}17$ elected members (including $7$ pharmacists with $2$ from hospitals, and $2$ technicians with $1$ from a hospital), $9\text{--}16$ public members appointed by the Lieutenant Governor in Council ($9$ appointed in 2024), and the Deans of the $3$ Ontario pharmacy faculties (University of Toronto, University of Waterloo, University of Ottawa).

Regulated Health Professions Act (RHPA)

The Ontario umbrella legislation establishing the standard framework of self-governance, scope of practice, controlled acts, public protection, and quality assurance across $26$ regulated health professions in Ontario.

Controlled Act

One of $14$ statutory healthcare procedures defined under Section 27(2) of the RHPA that poses potential risk to the public and can only be performed by individuals authorized by a profession-specific act or through valid legal delegation.

Health Professions Procedural Code

Schedule 2 of the Regulated Health Professions Act, 1991, which is embedded into every health profession act and establishes uniform administrative rules for member registration, complaint handling, investigations, discipline hearings, fitness to practise, quality assurance, and patient relations.

Health Professions Regulatory Advisory Council (HPRAC)

An independent, arms-length body appointed by the Lieutenant Governor in Council that advises the Minister of Health and Long-Term Care on regulatory amendments, whether unregulated professions should become regulated, and the quality assurance and patient relations programs of colleges.

Health Professions Appeal and Review Board (HPARB)

An independent third-party adjudicative board with the legal mandate to review registration and complaint decisions made by Ontario's health regulatory colleges.

Accreditation Committee (OCP)

A statutory committee under the Pharmacy Act responsible for reviewing matters relating to pharmacy operations in Ontario, including new applications, certificate renewals, and operational non-compliance identified during assessments.

Pharmacy Act Schedules (1 to 4)

Official regulatory lists established under the Pharmacy Act: Schedule 1 lists injectable medications; Schedule 2 lists inhaled substances; Schedule 3 lists authorized vaccines; and Schedule 4 lists medications authorized for pharmacist prescribing in minor ailments.

Ontario Drug Benefit Act (ODBA)

Provincial legislation that governs the funding and delivery of public prescription drug coverage in Ontario, applying specifically to ODB-eligible drugs listed in the Comparative Drug Index for designated recipient categories.

Trillium Drug Program (TDP)

An Ontario Drug Benefit program for Ontario residents with a valid health card who have high prescription drug costs in relation to their net household income and lack complete private insurance; requires payment of an income-based deductible divided across four quarters followed by a $2.00$ co-payment per prescription.

Comparative Drug Index (CDI)

The formal formulary document published in Part III-A of the ODB Formulary that lists drugs eligible for ODB coverage grouped by pharmacologic-therapeutic classification and designates which products are chemically and biologically interchangeable.

ODB Cost Sharing (Seniors)

The funding formula for ODB seniors ($65\,\text{years}$ and older): higher-income single seniors ($> \$25{,}000$) or couples ($> \$41{,}500$) pay a annual deductible of $\$100$ starting August 1st followed by a $\$6.11$ co-pay per prescription; lower-income seniors pay no deductible and a $\$2.00$ co-pay per prescription.

Canada Vigilance Adverse Drug Reaction Report Form

The formal federal document a physician must complete, sign, and submit to the pharmacy when claiming an ODB medically necessary 'No Substitution', verifying that the patient experienced documented significant adverse reactions to at least two interchangeable generic products.

Exceptional Access Program (EAP)

An ODB program that provides reimbursement for unlisted, high-cost drugs for severe, disabling clinical conditions where standard formulary alternatives have failed or are unsuitable; requires an Individual Clinical Review submitted exclusively by a physician and evaluated by the Committee to Evaluate Drugs.

Request for an Unlisted Drug Product (EAP Form)

The standard Ministry of Health application form submitted by a physician to request coverage under the Exceptional Access Program, outlining clinical diagnosis, previous failed formulary therapies, dosage details, and objective laboratory or clinical evidence.

Limited Use (LU) Product

A drug listed in Part XII of the ODB Formulary that is reimbursed only when a patient meets specific clinical criteria, confirmed by a physician communicating a valid $3\text{-digit}$ Reason for Use (RFU) code on the prescription.

ODB Trial Program

A policy mandating that new prescriptions for ODB recipients (medications not taken in the prior $12\,\text{months}$) be dispensed initially as a $30\text{-day}$ supply to assess tolerability, with exemptions for insulin, non-splittable dosage forms, or patients unable to return to the pharmacy within $30\,\text{days}$.

Vacation Supply (ODB)

An early refill policy permitting ODB recipients travelling outside Ontario for $100\text{--}200\,\text{days}$ to receive a second supply of up to a $100\text{-day}$ supply; the patient must provide travel documentation or a signed verification letter retained by the pharmacy on a separate file for $24\,\text{months}$.

Dispensing Fee Frequency Limit (ODB)

The ODB regulation capping reimbursement at a maximum of $5$ dispensing fees per patient per drug per benefit year across $15$ chronic medication categories; subsequent fills within the year reimburse only drug cost plus an $8\%$ markup with no co-pay.

MedsCheck Program

A publicly funded medication review service launched on April 1, 2007, reimbursing pharmacists for structured one-on-one reviews: Annual ($\$60$, follow-up $\$25$), Diabetes ($\$75$, follow-up $\$25$), MedsCheck at Home ($\$150$), and Long-Term Care ($\$90$ annual, $\$50 \times 3$ quarterly follow-ups).

Pharmaceutical Opinion Program

An ODB clinical service compensating pharmacists $\$15$ per eligible intervention when identifying a drug-related problem during dispensing or MedsCheck, documenting the issue, and providing a therapeutic recommendation to the prescriber.

Drug Interchangeability and Dispensing Fee Act (DIDFA)

Ontario provincial legislation that applies to all prescriptions dispensed in Ontario, governing the substitution of interchangeable drug products, patient notification rights, posting of dispensing fees, itemized receipts, and purchase invoice retention.

Interchangeable Drug (DIDFA)

A drug product designated by the Committee to Evaluate Drugs and the Executive Officer as chemically and biologically equivalent to another brand, containing the same active ingredients in identical strength and dosage form.

Notice to Patients (DIDFA Yellow Sign)

A mandatory informational poster displayed adjacent to the dispensary informing the public of the pharmacist's legal authority to dispense interchangeable products, the patient's right to request lower-cost alternatives, and the availability of professional consultation.

Off-Formulary Interchangeability (OFI)

A DIDFA provision found in Part III-B of the ODB Formulary that designates generic interchangeability for medications not funded under the public ODB benefit, enabling cost-saving generic substitutions for private-insurance and cash-paying patients.

Usual and Customary Dispensing Fee Notice

A standard notice posted visibly in every accredited dispensary showing the pharmacy's base dispensing fee as filed with the OCP Registrar, listing the bundle of professional services included in that fee without extra charge.

Health Network System (HNS)

The centralized electronic telecommunication network operated by the Ministry of Health that connects pharmacy software for real-time adjudication of claims, early refill checking, duplicate therapy warnings, and double-doctoring detection.

Transparent Drug Systems for Patients Act (TDSPA)

Ontario legislation also known as Bill 102 that enacted strict anti-rebate provisions under ODBA and DIDFA, prohibiting drug manufacturers and wholesalers from providing rebates or financial incentives to pharmacies for stocking or dispensing generic products.

Drug and Pharmacies Regulation Act (DPRA)

The provincial statute governing licensing, physical construction, sanitation, security, inspection, record-keeping, designated management, and operational standards for community pharmacies and remote dispensing facilities in Ontario.

Drug (DPRA Definition)

Any substance listed in NAPRA Schedules I, II, or III, or named in regulations, used to diagnose, treat, mitigate, or prevent disease, disorders, or abnormal states in humans, animals, or fowl, excluding food, drink, cosmetics, natural health products, and unscheduled products.

Compliance Packaging

Customized packaging such as blister packs or multi-medication packaging designed to organize doses by day and time, improve medication adherence, streamline administration workflows, and reduce dosing errors.

Bronchodilator Warning Label

A mandatory auxiliary warning label required under the DPRA for systemic adrenergic bronchodilators (e.g., salbutamol, epinephrine, ipratropium) stating: 'WARNING: Do not exceed the dose prescribed by your physician. If difficulty in breathing persists, contact your physician immediately.'

Child-Resistant Packaging

A certified safety container meeting Canadian Standards Association (CSA) specifications required for all dispensed prescriptions under the DPRA, unless directed otherwise by the prescriber, requested by the patient via a signed waiver, or contraindicated by the drug dosage form.

Child Resistant Package Rejection Form

A written direction signed by a patient or their agent requesting that all future prescriptions be dispensed in non-child-resistant containers (such as snap caps), which remains in force until revoked in writing.

Prescription Transfer (DPRA)

The formal transfer of remaining refills between accredited pharmacies (not individual pharmacists); the transferred prescription must be marked as 'Transferred' and becomes completely void and non-refillable at the transferring pharmacy.

Remote Dispensing Location (RDL)

A licensed retail site geographically separated from an accredited pharmacy where drugs are dispensed using an Automated Pharmacy System (APS) or telepharmacy dispensary under the real-time supervision of a pharmacist at the parent accredited pharmacy.

Automated Pharmacy System (APS)

A self-contained, highly secure, automated dispensing machine or kiosk located at a Remote Dispensing Location that executes the technical dispensing of medications without permitting public access to Schedule III drugs or narcotics.

Pharmacist Authority to Refill Prescriptions (DPRA)

The regulatory provision enacted in March 2011 authorizing a community pharmacist to refill an existing prescription for a chronic medication when the prescriber cannot be reached, limited to the lesser of the previous quantity or a $3\text{-month}$ supply, with mandatory physician notification within $7\,\text{days}$.

Patient Record Retention (DPRA)

The legal retention standard under the DPRA requiring complete patient records (dispensing records, profiles, MedsChecks, opinions, consultations, and waivers) to be kept for at least $10\,\text{years}$ from the last professional service or $10\,\text{years}$ after the patient turns $18\,\text{years}$ of age.

Designated Manager (DM)

A licensed Part A pharmacist appointed by the pharmacy owner and named on the Certificate of Accreditation who has ultimate legal responsibility for pharmacy operations, physical standards, staffing, and compliance with all provincial legislation.

Certificate of Accreditation

The official operating license issued by the Ontario College of Pharmacists authorizing a specific premise to operate as an accredited community pharmacy, requiring annual renewal by May 10th and mandatory public display.

Lock and Leave

An approved physical security system allowing the rest of a retail store to remain open while the dispensary is closed, requiring a physical barrier at least $2.44\,\text{m}$ ($8\,\text{feet}$) high, no more than $15\,\text{cm}$ off the floor, with all scheduled drugs kept at least $1\,\text{m}$ behind the barrier and the dispensary telephone disconnected.

Point of Care Symbol

A registered emblem consisting of a green cross and the Bowl of Hygeia that identifies an accredited pharmacy providing professional pharmaceutical care and must be prominently posted at or near at least one public entrance to the premises.

Piggybacking

The prohibited practice of taking authorized refill quantities from a newly received prescription and adding them onto remaining repeats of an existing prescription for the same medication; the remaining repeats on the older order must be cancelled.